Vulvar cancer accounts for less than 1% of malignancies in women. Verrucous
carcinoma of the vulva is a rare histological variation, comprising less than 1%
of vulvar cancer cases. Although it is characterized as being locally invasive,
the condition is not associated with metastatic spreading. Lesions present in
the form of a verrucous, ulcerated, and bleeding tumor that can reach large
dimensions. This type of tumor can be mistaken for condylomata, both
macroscopically and microscopically. We report the case of an 81-year-old
patient with a large vulvar tumor presented for eight years, initially
considered as a Buschke-Löwenstein tumor. The patient underwent radical
vulvectomy with a V-Y advancement flap technique. This type of tumor should be
considered by clinicians dealing with condylomatous ulcerative lesions that do
not respond to the usual treatment.
Cancer of the vulva accounts for at least 1% of malignant neoplasms among women.
Although rare, vulvar melanoma is the second most common histological type of
vulvar cancer, representing 7-10% of all malignant vulvar neoplasms. Initial
symptoms are non-specific and complete excision of the lesion is indicated in
cases with suspected diagnosis. Prognosis of patients with these neoplasms is
poor and remains unchanged despite the treatment approach. Hemivulvectomy with
lymph node dissection is the current procedure of choice, associated or not with
adjuvant therapies. We report two cases of patients presenting with late
diagnosed vulvar melanoma and the relevant aspects in their therapeutic
management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.